Back to search

Sweden· SE-20050722000035

Glucose-Na-K Baxter 50 mg/ml Infusionsvätska, lösning

A medicinal product containing magnesium chloride hexahydrate + potassium chloride + sodium chloride + glucose + sodium acetate trihydrate, registered in Sweden by Baxter Medical AB.

Checked against Swedish Medical Products Agency (Sweden) on

Informational only — not a medical device.

SOURCE REGISTER · SESwedish Medical Products Agency (Sweden)normalisedGlucose-Na-K Baxter 50 mg/ml Infusion…ATC—REGISTER NO.SE-20050722000035PACKS LISTED1CHECKEDOctober 1, 2026

The record

At a glance

Swedish Medical Products Agency (Sweden)
Active substance
Magnesium Chloride Hexahydrate + Potassium Chloride + Sodium Chloride + Glucose + Sodium Acetate Trihydrate
Manufacturer
Baxter Medical AB
Country
Sweden (SE)
ATC code
—
Reimbursed
Not published by this register
Source register
Swedish Medical Products Agency (Sweden)
Last checked
October 1, 2026

Packs & prices · 1

  • se_varunummer
    20050722000035

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Magnesium chloride hexahydrate + potassium chloride + sodium chloride + glucose + sodium acetate trihydrate in 7 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All magnesium chloride hexahydrate + potassium chloride + sodium chloride + glucose + sodium acetate trihydrate products

Authorised across Europe · EMA

The same active substance is authorised in 24 EEA countries. Names it is sold under:

  • Belgium · Plasmalyte 148, Plasmalyte 148 Viaflo
  • Bulgaria · Гнак
  • Cyprus · Maintelyte, Plasmalyte + Glucose 5%
  • Czechia · Gnak, Plasmalyte S Glukózou
  • Germany · Maintelyte
  • Denmark · Glucose-Na-K Baxter, Plasmalyte
  • Spain · Maintelyte, Viaflo Plasmalyte 148 Y Glucosa
  • Finland · Glucose-Na-K Baxter, Plasmalyte Glucos
  • France · Maintelyte, Plasmalyte Et Glucose
  • United Kingdom (Northern Ireland) · Maintelyte, Plasma-Lyte 148
  • Greece · Maintelyte, Plasmalyte + Glucose 5%
  • Croatia · Gnak, Plasmalyte + Glucose
  • Ireland · Maintelyte, Plasma-Lyte 148 & Glucose
  • Iceland · Plasmalyte Glucos
  • Italy · Crystalglu, Elettrolitica Bilanciata Di Mantenimento Con Glucosio Fresenius Kabi Italia
  • Luxembourg · Plasmalyte 148 + Glucose Viaflo, Plasmalyte 148 Viaflo
  • Malta · Maintelyte, Plasma-Lyte 148 & Glucose
  • Netherlands · Maintelyte, Plasma-Lyte 148 + Glucose
  • Norway · Glucose-Na-K Baxter, Karbolytt
  • Poland · Gnak
  • Portugal · Maintelyte, Plasma-Lyte 148 E Glucose Viaflo
  • Romania · Gnak
  • Slovenia · Gnak, Plasmalyte Z Glukozo
  • Slovakia · Gnak, Plasmalyte + Glucose 5%

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b35ea358-cb75-4f7a-89b6-75dbf553ce1e
GET /v1/drugs/b35ea358-cb75-4f7a-89b6-75dbf553ce1e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "source": "lakemedelsverket",
  "doc_types": [
    "sPAR",
    "SmPC",
    "PL",
    "PAR"
  ],
  "se_npl_id": "20050722000035",
  "product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20050722000035",
  "product_doc_link": "https://docetp.mpa.se/LMF/Glucose-Na-K%20Baxter%2050%20mg%20per%20ml%20solution%20for%20infusion%20SmPC_09001bee807a3cfc.pdf"
}

See everything about magnesium chloride hexahydrate + potassium chloride + sodium chloride + glucose + sodium acetate trihydrate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.